Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Mathea

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Cell Death and Differentiation|October 8, 2016
Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerizationJakob Gebel, Laura M Luh, Daniel Coutandin, et al.
Plos Biology|February 22, 2022
LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJui-Hung Weng, Phillip C Aoto, Robin Lorenz, et al.
Molecular Cell|July 4, 2020
Structural Insights into Pseudokinase Domains of Receptor Tyrosine KinasesJoshua B Sheetz, Sebastian Mathea, Hanna Karvonen, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
ACS Chemical Biology|March 22, 2016
Structure of the Human Protein Kinase ZAK in Complex with VemurafenibSebastian Mathea, Kamal R Abdul Azeez, Eidarus Salah, et al.
Elife|March 30, 2016
Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular levelDaniel Coutandin, Christian Osterburg, Ratnesh Kumar Srivastav, et al.
Journal of Medicinal Chemistry|May 24, 2022
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based MacrocyclesChristian G Kurz, Franziska Preuss, Amelie Tjaden, et al.
Science Advances|June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Plos Biology|February 3, 2025
Correction: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJui-Hung Weng, Phillip C Aoto, Robin Lorenz, et al.
Journal of Medicinal Chemistry|September 10, 2021
Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical ProbeSandra Röhm, Benedict-Tilman Berger, Martin Schröder, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Cell Death and Differentiation|October 8, 2016
Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerizationJakob Gebel, Laura M Luh, Daniel Coutandin, et al.
Plos Biology|February 22, 2022
LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJui-Hung Weng, Phillip C Aoto, Robin Lorenz, et al.
Molecular Cell|July 4, 2020
Structural Insights into Pseudokinase Domains of Receptor Tyrosine KinasesJoshua B Sheetz, Sebastian Mathea, Hanna Karvonen, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
ACS Chemical Biology|March 22, 2016
Structure of the Human Protein Kinase ZAK in Complex with VemurafenibSebastian Mathea, Kamal R Abdul Azeez, Eidarus Salah, et al.
Elife|March 30, 2016
Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular levelDaniel Coutandin, Christian Osterburg, Ratnesh Kumar Srivastav, et al.
Journal of Medicinal Chemistry|May 24, 2022
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based MacrocyclesChristian G Kurz, Franziska Preuss, Amelie Tjaden, et al.
Science Advances|June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Plos Biology|February 3, 2025
Correction: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJui-Hung Weng, Phillip C Aoto, Robin Lorenz, et al.
Journal of Medicinal Chemistry|September 10, 2021
Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical ProbeSandra Röhm, Benedict-Tilman Berger, Martin Schröder, et al.
Pageof 6